MAPT and Alzheimer disease: The PI3K/Akt pathway in the brain of AD patients was downregulated, and upregulation of the PI3K/Akt pathway can significantly reduce Tau-induced neurotoxicity and Aβ deposition by activating the PI3K/Akt pathway [34, 35].